Clindamycin Injection, Solution
Product Images NDC 71872-7192

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Clindamycin (NDC 71872-7192). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71872-7192-1.pdp (71872 7192 1)

Drug facts and usage information for Clindamycin Injection, USP 600 mg per 4 mL (150 mg per mL) in a 4 mL single-dose vial. Instructions include IM or IV use, dilution before IV use, storage conditions, and components per mL such as clindamycin phosphate, disodium edetate, and benzyl alcohol. Manufacturer and distributor details are also provided.*

FDA Label Image

Structural Formula (Cli04 0015 01)

Chemical structure diagram depicting the molecular structure of clindamycin phosphate, the active ingredient in Clindamycin injection solution 150 mg/mL, used for intramuscular and intravenous administration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.